Swift Medical, the global leader in digital wound care, announced recently a Series B funding round of $35 million USD. This latest round of funding will help Swift Medical expand their leading market position and scale their digital wound management platform across the care continuum in North America.
Swift Medical is a former OBIO CAAP Company.